2013
DOI: 10.1016/j.jprot.2013.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
45
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(46 citation statements)
references
References 49 publications
0
45
0
1
Order By: Relevance
“…These types of in silico analysis include annotated databases and metabolic and signaling pathways gathered from publications. Protein names were manually inserted in the system and all interactions processed considering canonical paths (Landiet al, ).…”
Section: Methodsmentioning
confidence: 99%
“…These types of in silico analysis include annotated databases and metabolic and signaling pathways gathered from publications. Protein names were manually inserted in the system and all interactions processed considering canonical paths (Landiet al, ).…”
Section: Methodsmentioning
confidence: 99%
“…There are multiple technologies and methods for peptide fractionation, enrichment, ionization and types of mass spectrometers commercially available . MS has been used widely in biomarker studies of respiratory disease to date including chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS) and interstitial lung disease (ILD) …”
Section: Proteomic Applications and Challengesmentioning
confidence: 99%
“…Protein profiles specific to Ventilator-associated pneumonia (VAP) were readily identified in BALF, offering promising candidates for understanding the mechanism driving VAP [142]. Likewise, protein signatures of sarcoidosis, IPF, pulmonary langerhans cell histiocytosis, PF due to systemic sclerosis were highlighted, and using systems biology platforms, common and distinct pathways were identified [143]. Intriguingly, phosphoproteomics on lung tissues of lung cancer and COPD patients revealed that activation of the NF-κB pathway was the most relevant signaling link between the two diseases, providing clues to developing therapies [144148].…”
Section: Proteomics and Metabolomics In Pulmonary Biologymentioning
confidence: 99%